A new trading day began on Tuesday, with Mirum Pharmaceuticals Inc (NASDAQ: MIRM) stock price up 4.60% from the previous day of trading, before settling in for the closing price of $64.1. MIRM’s price has ranged from $36.88 to $78.54 over the past 52 weeks.
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 4.14%. Meanwhile, its annual earnings per share averaged 80.16%. With a float of $42.49 million, this company’s outstanding shares have now reached $51.31 million.
Considering the fact that the conglomerate employs 322 people, you should pay attention to its efficiency factor.
Mirum Pharmaceuticals Inc (MIRM) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Mirum Pharmaceuticals Inc is 17.79%, while institutional ownership is 96.39%. The most recent insider transaction that took place on Dec 01 ’25, was worth 3,700,000. In this transaction Director of this company sold 50,000 shares at a rate of $74.00, taking the stock ownership to the 0 shares. Before that another transaction happened on Dec 01 ’25, when Company’s Director proposed sale 50,000 for $74.00, making the entire transaction worth $3,700,000.
Mirum Pharmaceuticals Inc (MIRM) Recent Fiscal highlights
In its latest quarterly report, released on 12/31/2024, the company reported earnings of -0.49 per share, which was $0.1 lower than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.05 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 80.16% per share during the next fiscal year.
Mirum Pharmaceuticals Inc (NASDAQ: MIRM) Trading Performance Indicators
Here are Mirum Pharmaceuticals Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 3.16. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 7.35. Likewise, its price to free cash flow for the trailing twelve months is 78.19.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.86, a number that is poised to hit -0.05 in the next quarter and is forecasted to reach -0.22 in one year’s time.
Technical Analysis of Mirum Pharmaceuticals Inc (MIRM)
Compared to the last year’s volume of 0.56 million, its volume of 0.75 million showed improvement in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 23.82%.
During the past 100 days, Mirum Pharmaceuticals Inc’s (MIRM) raw stochastic average was set at 59.38%, which indicates a significant increase from 32.55% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 3.05 in the past 14 days, which was higher than the 2.68 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $70.54, while its 200-day Moving Average is $57.77. Nevertheless, the first resistance level for the watch stands at $68.63 in the near term. At $70.20, the stock is likely to face the second major resistance level. The third major resistance level sits at $72.27. If the price goes on to break the first support level at $64.98, it is likely to go to the next support level at $62.91. Now, if the price goes above the second support level, the third support stands at $61.34.
Mirum Pharmaceuticals Inc (NASDAQ: MIRM) Key Stats
With a market capitalization of 3.47 billion, the company has a total of 51,394K Shares Outstanding. Currently, annual sales are 336,890 K while annual income is -87,940 K. The company’s previous quarter sales were 133,010 K while its latest quarter income was 2,910 K.
